Literature DB >> 22209526

Association of degree and type of edema in posterior reversible encephalopathy syndrome with serum lactate dehydrogenase level: initial experience.

Bo Gao1, Feng-li Liu, Bin Zhao.   

Abstract

PURPOSE: Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiologic entity characterized by headache, blurred vision and seizures with typical parieto-occipital predominantly vasogenic edema, occasionally with cytotoxic edema. The association between the degree and type of edema in PRES with biochemical parameter, especially serum lactate dehydrogenase, has not been determined.
MATERIAL AND METHODS: Thirty-five patients with typical clinical symptoms and characteristic MR imaging findings of PRES were included in this study. The extent of brain edema was graded on the anatomical distribution by 2 observers blinded to patients' clinical record, as well as the type of brain edema determined on DWI and ADC map. The levels of biochemical parameters were correlated with the degree of edema and compared between different types of edema.
RESULTS: Serum LDH concentrations between patients with cytotoxic edema and with vasogenic components were not statistically different (NWU test, U=93.0, Z=1.818, P=0.069). Only serum lactate dehydrogenase (LDH) concentration was significantly correlated with the score of brain edema distribution (Spearman's rho correlation, r=0.721, P=0.00). No relationship was found between other biochemical parameters and the degree and type of brain edema.
CONCLUSION: Increased serum LDH level, which plays an essential role in endothelial injury, may be a potential risk factor for the development of edema in PRES. Crown
Copyright © 2011. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22209526     DOI: 10.1016/j.ejrad.2011.12.010

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  12 in total

1.  Serum lactate dehydrogenase as a predictor of outcome in posterior reversible encephalopathy syndrome: imperative to unify.

Authors:  C Lv; B Gao
Journal:  AJNR Am J Neuroradiol       Date:  2015-01-22       Impact factor: 3.825

2.  Reply: To PMID 24722310.

Authors:  R Verma; V Junewar
Journal:  AJNR Am J Neuroradiol       Date:  2015-01-22       Impact factor: 3.825

3.  Effect of blood pressure on reversible posterior leukoencephalopathy syndrome in pre-eclampsia or eclampsia.

Authors:  Fang Xiaobo; Liang Yanling; Chen Dunjin; He Fang; Chen Jia; Zhong Yuhua; Zhang Weixi
Journal:  Hypertens Res       Date:  2017-11-02       Impact factor: 3.872

4.  Cytotoxic Edema in Posterior Reversible Encephalopathy Syndrome: Correlation of MRI Features with Serum Albumin Levels.

Authors:  B Gao; B X Yu; R S Li; G Zhang; H Z Xie; F L Liu; C Lv
Journal:  AJNR Am J Neuroradiol       Date:  2015-07-02       Impact factor: 3.825

5.  Neuroimaging features and predictors of outcome in eclamptic encephalopathy: a prospective observational study.

Authors:  V Junewar; R Verma; P L Sankhwar; R K Garg; M K Singh; H S Malhotra; P K Sharma; A Parihar
Journal:  AJNR Am J Neuroradiol       Date:  2014-04-10       Impact factor: 3.825

6.  The clinical characteristics of posterior reversible encephalopathy syndrome in patients with chronic renal failure.

Authors:  Hongtao Hu; Shen Xu; Shuang Hu; Weijia Xu; Hua Shui
Journal:  Exp Ther Med       Date:  2017-06-08       Impact factor: 2.447

7.  Risk factors for poor outcome in posterior reversible encephalopathy syndrome: systematic review and meta-analysis.

Authors:  Zheng Chen; Gang Zhang; Alexander Lerner; An-Hui Wang; Bo Gao; Jie Liu
Journal:  Quant Imaging Med Surg       Date:  2018-05

8.  Management of posterior reversible syndrome in preeclamptic women.

Authors:  S Poma; M P Delmonte; C Gigliuto; R Imberti; M Delmonte; A Arossa; G A Iotti
Journal:  Case Rep Obstet Gynecol       Date:  2014-11-19

9.  A reversible posterior leucoencephalopathy syndrome including blindness caused by preeclampsia.

Authors:  G Vandenbossche; J Maquet; P Vroonen; G Lambert; M Nisolle; F Kridelka; E Emonts
Journal:  Facts Views Vis Obgyn       Date:  2016-09

10.  Chemotherapy-induced posterior reversible encephalopathy syndrome: Three case reports.

Authors:  Bernardo Cacho-Díaz; Nydia A Lorenzana-Mendoza; Karen Salmerón-Moreno; Gervith Reyes-Soto; Carlos Castillo-Rangel; Roberto Corona-Cedillo; Salvador Escobar-Ceballos; Jaime G de la Garza-Salazar
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.